Fayette Oncology Associates
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 5,229,211 | 5,228,287 | 924 | 3.1 | 18% |
| 2012 | 4,514,595 | 4,514,595 | 0 | 2.7 | 21% |
| 2013 | 4,169,050 | 4,169,050 | 0 | 2.7 | 21% |
| 2014 | 3,740,480 | 3,743,442 | −2,962 | 3.0 | 30% |
| 2015 | 3,453,589 | 3,477,314 | −23,725 | 3.8 | 31% |
| 2016 | 3,510,452 | 3,510,452 | 0 | 5.6 | 30% |
| 2017 | 3,739,090 | 3,739,090 | 0 | 6.0 | 28% |
| 2018 | 4,014,518 | 4,014,518 | 0 | 6.8 | 27% |
| 2019 | 3,894,608 | 3,894,608 | 0 | 8.8 | 29% |
| 2020 | 3,582,226 | 3,582,226 | 0 | 9.6 | 31% |
| 2021 | 3,551,220 | 3,373,918 | 177,302 | 10.5 | 39% |
| 2022 | 3,437,539 | 3,437,539 | 0 | 10.9 | 37% |
| 2023 | 3,580,442 | 3,580,442 | 0 | 12.1 | 37% |
In its most recent public year (2023), this organization brought in $0 more than it spent. Its reserves stood at about 12.1 months of spending, up from 3.1 in 2011. Staff pay was 37% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Fayette Oncology Associates's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works